• Bryan Johnson

    Data from my first longevity gene therapy: 160% increase in follistatin levels. Achieving our target objective.

    This therapy ranks 7th among lifespan studies, extending mouse lifespan by 30%.

    Goals:
    . epigenetic age reduction
    . monitoring dozen+ organs for possible…

    Tweet media